Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 10:12:e52544.
doi: 10.2196/52544.

Benefits and Barriers to mHealth in Hypertension Care: Qualitative Study With German Health Care Professionals

Susann May  1   2 , Felix Muehlensiepen  1   2 , Eileen Wengemuth  1   2 , Frances Seifert  1   2 , Martin Heinze  3 , Dunja Bruch  2 , Sebastian Spethmann  4   5   6
Affiliations

Benefits and Barriers to mHealth in Hypertension Care: Qualitative Study With German Health Care Professionals

Susann May et al. JMIR Hum Factors. .

Abstract

Background: Digital health technologies, particularly mobile health (mHealth) apps and wearable devices, have emerged as crucial assets in the battle against hypertension. By enabling lifestyle modifications, facilitating home blood pressure monitoring, and promoting treatment adherence, these technologies have significantly enhanced hypertension treatment.

Objective: This study aims to explore the perspectives of health care professionals (HCPs) regarding the perceived benefits and barriers associated with the integration of mHealth apps into routine hypertension care. Additionally, strategies for overcoming these barriers will be identified.

Methods: Through qualitative analysis via semistructured interviews, general practitioners (n=10), cardiologists (n=14), and nurses (n=3) were purposefully selected between October 2022 and March 2023. Verbatim transcripts were analyzed using qualitative content analysis.

Results: The results unveiled 3 overarching themes highlighting the benefits of mHealth apps in hypertension care from the perspective of HCPs. First, these technologies possess the potential to enhance patient safety by facilitating continuous monitoring and early detection of abnormalities. Second, they can empower patients, fostering autonomy in managing their health conditions, thereby promoting active participation in their care. Lastly, mHealth apps may provide valuable support to medical care by offering real-time data that aids in decision-making and treatment adjustments. Despite these benefits, the study identified several barriers hindering the seamless integration of mHealth apps into hypertension care. Challenges predominantly revolved around data management, communication contexts, daily routines, and system handling. HCPs underscored the necessity for structural and procedural modifications in their daily practices to effectively address these challenges.

Conclusions: In conclusion, the effective usage of digital tools such as mHealth apps necessitates overcoming various obstacles. This entails meeting the information needs of both HCPs and patients, tackling interoperability issues to ensure seamless data exchange between different systems, clarifying uncertainties surrounding reimbursement policies, and establishing the specific clinical benefits of these technologies. Active engagement of users throughout the design and implementation phases is crucial for ensuring the usability and acceptance of mHealth apps. Moreover, enhancing knowledge accessibility through the provision of easily understandable information about mHealth apps is essential for eliminating barriers and fostering their widespread adoption in hypertension care.

Trial registration: German Clinical Trials Register DRKS00029761; https://drks.de/search/de/trial/DRKS00029761.

International registered report identifier (irrid): RR2-10.3389/fcvm.2022.1089968.

Keywords: Germany; HCP; blood pressure monitoring; cardiologists; digital health; general practitioners; health care professional; hypertension; mHealth; mHealth apps; nurses; physicians; qualitative content analysis; qualitative interviews; qualitative study.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Coding tree of the benefits regarding mHealth apps in hypertension prevention. mHealth: mobile health.
Figure 2
Figure 2
Coding tree of the barriers regarding mHealth apps in hypertension prevention. mHealth: mobile health.
Figure 3
Figure 3
Coding tree of the recommendations for successful integration of mHealth apps into the health care landscape. mHealth: mobile health.
See this image and copyright information in PMC

References

    1. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-Guzman N, Azzopardi P, Banerjee A, Bärnighausen T, Basu A, Bekele T, Bennett DA, Biadgilign S, Catalá-López F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey GJ, Jonas JB, Judd SE, Khang Y, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, Kolte D, Lopez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngalesoni FN, Ohkubo T, Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney M, Schutte AE, Sepanlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, Truelsen T, Tsilimparis N, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, Yonemoto N, Zaki MES, Murray CJL. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. J Am Med Assoc. 2017;317(2):165–182. doi: 10.1001/jama.2016.19043. https://research-repository.uwa.edu.au/en/publications/global-burden-of-... 2596292 - DOI - PubMed
    1. Neuhauser H, Kuhnert R, Born S. 12-Month prevalence of hypertension in Germany. J Health Monit. 2017;2(1):51–57. doi: 10.17886/RKI-GBE-2017-016. https://europepmc.org/abstract/MED/37151301 - DOI - PMC - PubMed
    1. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785–802. doi: 10.1038/s41569-021-00559-8. https://europepmc.org/abstract/MED/34050340 10.1038/s41569-021-00559-8 - DOI - PMC - PubMed
    1. Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, Damasceno A, Delles C, Gimenez-Roqueplo AP, Hering D, López-Jaramillo P, Martinez F, Perkovic V, Rietzschel ER, Schillaci G, Schutte AE, Scuteri A, Sharman JE, Wachtell K, Wang JG. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on Hypertension. Lancet. 2016;388(10060):2665–2712. doi: 10.1016/S0140-6736(16)31134-5.S0140-6736(16)31134-5 - DOI - PubMed
    1. Parati G, Goncalves A, Soergel D, Bruno RM, Caiani EG, Gerdts E, Mahfoud F, Mantovani L, McManus RJ, Santalucia P, Kahan T. New perspectives for hypertension management: progress in methodological and technological developments. Eur J Prev Cardiol. 2023;30(1):48–60. doi: 10.1093/eurjpc/zwac203.6693942 - DOI - PubMed

LinkOut - more resources